Vuno receives second 510(k)
South Korean medical AI company Vuno has obtained a 510(k) clearance from the United States Food and Drug Administration for its chest X-ray analysis AI software.
The VunoMed Chest X-ray Triage quickly screens for pneumothorax and pleural effusion in chest X-ray images.
This FDA win is a second for Vuno, who first received a 510(k) for its brain image analysis AI in...
A new company under financial investment firm SOL Partnership has launched what could be the first at-home gut health test service powered by AI in Malaysia.
SpaceGut offers an at-home gut microbiome kit and a laboratory service that provides personalised recommendations for an individual's gut health. Leveraging a proprietary AI, its laboratory evaluates samples compared against a database of...
Lunit collabs with AstraZeneca, secures major deal in France
Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims to accelerate the time-consuming process of genomic testing as part of NSCLC identification and diagnosis by leveraging Lunit's AI. The latter's...
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.
According to a press statement, the following organisations will collaborate to develop and test AI for identifying novel drug candidates and predicting its efficacy:
DAAN Cancer Research Institute under Yonsei...
The Society of General Internal Medicine released a position statement on generative AI use in healthcare, highlighting the need for clinicians and technologists to partner to enhance genAI decision-making and for healthcare organizations to use the technology but, avoid "the urge to rapidly displace the human clinical workforce with generative AI."
The Society says clinicians must remain...
Founder and former CEO of the London-based multinational digital health giant Babylon, Ali Parsa, announced the launch of his new company, Quadrivia AI, which will offer clinicians an AI assistant to help with administrative and clinical tasks.
Quadrivia's offering, Qu, is an AI-enabled personal clinical assistant available in multiple languages designed to support clinicians with various tasks...
Neurophet sets up China JV
Medical imaging AI company Neurophet from South Korea has established a joint venture in China.
It recently signed an exclusive deal with LADO, one of the leading medical software providers in China, to market its AI-based software for quantifying levels of Alzheimer's disease biomarkers in PET images.
The deal, which also establishes a joint venture with LADO, aims...
Health Catalyst, a U.S.-based provider of healthcare data and analytics for care organizations, signed a definitive agreement to acquire all equity interests of cybersecurity provider Intraprise Health for an aggregate purchase price of approximately $43 million.
Intraprise offers an end-to-end cybersecurity risk management and services platform, while Health Catalyst's healthcare data and...
AI startup Research Grid, which helps medical research institutions automate administrative tasks for clinical trials, announced it raised $6.5 million in seed funding.
Fuel Ventures led the round with participation from Ada Ventures, Arve Capital, Arāya Ventures, Morgan Stanley Inclusive Ventures Lab, Plug and Play Ventures, Atomico Angels and Ascension Ventures.
WHAT IT DOES
Research Grid is...
South Korean medical AI company AITRICS has obtained clearance from the Ministry of Health, Vietnam for its AI software for predicting patient deterioration.
VitalCare utilises AI to analyse 19 types of EMR data of patients in general wards to predict possible death, ICU transfer, and cardiac arrest within six hours. It can also predict sepsis within four hours, cardiac arrest within 24 hours, as...
